Skip to main content

Table 2 Subject demographics

From: A randomized, double blind, placebo and active comparator controlled pilot study of UP446, a novel dual pathway inhibitor anti-inflammatory agent of botanical origin

  UP446250 mg/day UP446500 mg/day Celecoxib200 mg/day Placebo
Total (N) 15 15 15 15
Mean (SD) Age 62.8 (10.8) 54.6 (14.8) 57.6 (12.6) 55.3 (14.3)
Male N (%) 5 (33) 6 (40) 5 (33) 6 (40)
Female N (%) 10 (67) 9 (60) 10 (67) 9 (60)